Horn Kinney 4
4 · Olema Pharmaceuticals, Inc. · Filed Mar 14, 2022
Insider Transaction Report
Form 4
Horn Kinney
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2022-03-10$2.06/sh+5,253$10,842→ 7,711 total - Sale
Common Stock
2022-03-10$4.75/sh−5,253$24,952→ 2,458 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-10−5,253→ 141,785 totalExercise: $2.06Exp: 2030-06-10→ Common Stock (5,253 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- [F2]The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date.